These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 28028556)

  • 1. Effect of intravenous gadoxetate disodium and flip angle on hepatic proton density fat fraction estimation with six-echo, gradient-recalled-echo, magnitude-based MR imaging at 3T.
    Park CC; Hamilton G; Desai A; Zand KA; Wolfson T; Hooker JC; Costa E; Heba E; Clark L; Gamst A; Loomba R; Middleton MS; Sirlin CB
    Abdom Radiol (NY); 2017 Apr; 42(4):1189-1198. PubMed ID: 28028556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of multiecho magnitude-based MRI (M-MRI) for estimation of hepatic proton density fat fraction (PDFF) in children.
    Zand KA; Shah A; Heba E; Wolfson T; Hamilton G; Lam J; Chen J; Hooker JC; Gamst AC; Middleton MS; Schwimmer JB; Sirlin CB
    J Magn Reson Imaging; 2015 Nov; 42(5):1223-32. PubMed ID: 25847512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of a high-SNR chemical-shift-encoded MRI with complex reconstruction for proton density fat fraction (PDFF) estimation overall and in the low-fat range.
    Park CC; Hooker C; Hooker JC; Bass E; Haufe W; Schlein A; Covarrubias Y; Heba E; Bydder M; Wolfson T; Gamst A; Loomba R; Schwimmer J; Hernando D; Reeder SB; Middleton M; Sirlin CB; Hamilton G
    J Magn Reson Imaging; 2019 Jan; 49(1):229-238. PubMed ID: 29707848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra- and inter-examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction in overweight and obese children and adults.
    Tyagi A; Yeganeh O; Levin Y; Hooker JC; Hamilton GC; Wolfson T; Gamst A; Zand AK; Heba E; Loomba R; Schwimmer J; Middleton MS; Sirlin CB
    Abdom Imaging; 2015 Oct; 40(8):3070-7. PubMed ID: 26350282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy and the effect of possible subject-based confounders of magnitude-based MRI for estimating hepatic proton density fat fraction in adults, using MR spectroscopy as reference.
    Heba ER; Desai A; Zand KA; Hamilton G; Wolfson T; Schlein AN; Gamst A; Loomba R; Sirlin CB; Middleton MS
    J Magn Reson Imaging; 2016 Feb; 43(2):398-406. PubMed ID: 26201284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agreement between region-of-interest- and parametric map-based hepatic proton density fat fraction estimation in adults with chronic liver disease.
    Manning PM; Hamilton G; Wang K; Park C; Hooker JC; Wolfson T; Gamst A; Haufe WM; Schlein AN; Middleton MS; Sirlin CB
    Abdom Radiol (NY); 2017 Mar; 42(3):833-841. PubMed ID: 27688063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of flip angle on the accuracy and repeatability of hepatic proton density fat fraction estimation by complex data-based, T1-independent, T2*-corrected, spectrum-modeled MRI.
    Johnson BL; Schroeder ME; Wolfson T; Gamst AC; Hamilton G; Shiehmorteza M; Loomba R; Schwimmer JB; Reeder S; Middleton MS; Sirlin CB
    J Magn Reson Imaging; 2014 Feb; 39(2):440-7. PubMed ID: 23596052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms.
    Kang GH; Cruite I; Shiehmorteza M; Wolfson T; Gamst AC; Hamilton G; Bydder M; Middleton MS; Sirlin CB
    J Magn Reson Imaging; 2011 Oct; 34(4):928-34. PubMed ID: 21769986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI proton density fat fraction is robust across the biologically plausible range of triglyceride spectra in adults with nonalcoholic steatohepatitis.
    Hong CW; Mamidipalli A; Hooker JC; Hamilton G; Wolfson T; Chen DH; Fazeli Dehkordy S; Middleton MS; Reeder SB; Loomba R; Sirlin CB
    J Magn Reson Imaging; 2018 Apr; 47(4):995-1002. PubMed ID: 28851124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Gadoxetate disodium to the hepatic proton density fat fraction quantified with the Dixon sequences in a rabbit model.
    Wang X; Zhang S; Huang Z; Tian G; Liu X; Chen L; An L; Li X; Liu N; Ji Y; Han Y
    Abdom Radiol (NY); 2024 Oct; 49(10):3374-3382. PubMed ID: 38683216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of PDFF estimation by magnitude-based and complex-based MRI in children with MR spectroscopy as a reference.
    Haufe WM; Wolfson T; Hooker CA; Hooker JC; Covarrubias Y; Schlein AN; Hamilton G; Middleton MS; Angeles JE; Hernando D; Reeder SB; Schwimmer JB; Sirlin CB
    J Magn Reson Imaging; 2017 Dec; 46(6):1641-1647. PubMed ID: 28323377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?
    Satkunasingham J; Nik HH; Fischer S; Menezes R; Selzner N; Cattral M; Grant D; Jhaveri K
    Liver Transpl; 2018 Apr; 24(4):470-477. PubMed ID: 29080242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproducibility of MR-based liver fat quantification across field strength: Same-day comparison between 1.5T and 3T in obese subjects.
    Artz NS; Haufe WM; Hooker CA; Hamilton G; Wolfson T; Campos GM; Gamst AC; Schwimmer JB; Sirlin CB; Reeder SB
    J Magn Reson Imaging; 2015 Sep; 42(3):811-7. PubMed ID: 25620624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of and agreement between MR imaging and spectroscopic estimation of hepatic proton density fat fraction in children with known or suspected nonalcoholic fatty liver disease.
    Achmad E; Yokoo T; Hamilton G; Heba ER; Hooker JC; Changchien C; Schroeder M; Wolfson T; Gamst A; Schwimmer JB; Lavine JE; Sirlin CB; Middleton MS
    Abdom Imaging; 2015 Oct; 40(8):3084-90. PubMed ID: 26205992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.
    Idilman IS; Keskin O; Celik A; Savas B; Elhan AH; Idilman R; Karcaaltincaba M
    Acta Radiol; 2016 Mar; 57(3):271-8. PubMed ID: 25855666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of liver proton density fat fraction and changes in R 2* measurements induced by administering gadoxetic acid at 3T MRI.
    Sofue K; Zhong X; Nickel MD; Dale BM; Bashir MR
    Abdom Radiol (NY); 2016 Aug; 41(8):1555-64. PubMed ID: 27052456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver MRI in the hepatocyte phase with gadolinium-EOB-DTPA: does increasing the flip angle improve conspicuity and detection rate of hypointense lesions?
    Bashir MR; Husarik DB; Ziemlewicz TJ; Gupta RT; Boll DT; Merkle EM
    J Magn Reson Imaging; 2012 Mar; 35(3):611-6. PubMed ID: 22034383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy.
    Idilman IS; Aniktar H; Idilman R; Kabacam G; Savas B; Elhan A; Celik A; Bahar K; Karcaaltincaba M
    Radiology; 2013 Jun; 267(3):767-75. PubMed ID: 23382293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic steatosis: effect on hepatocyte enhancement with gadoxetate disodium-enhanced liver MR imaging.
    Onishi H; Theisen D; Dietrich O; Reiser MF; Zech CJ
    J Magn Reson Imaging; 2014 Jan; 39(1):42-50. PubMed ID: 24339365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents.
    Zhao YZ; Gan YG; Zhou JL; Liu JQ; Cao WG; Cheng SM; Bai DM; Wang MZ; Gao FQ; Zhou SM
    World J Gastroenterol; 2019 Mar; 25(12):1513-1523. PubMed ID: 30948914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.